42
Participants
Start Date
July 13, 2018
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
ASP7317
subretinal injection
tacrolimus
oral
trimethoprim-sulfamethoxazole
oral
Acyclovir
oral
Nystatin
oral
RECRUITING
Mid-Atlantic Retina, Philadelphia
RECRUITING
Emory University Eye Center, Atlanta
WITHDRAWN
Retina Consultants of Southwest Florida & National Ophthalmic Research Institute, Fort Myers
RECRUITING
Retina Specialty Institute, Pensacola
WITHDRAWN
Tennessee Retina, PC, Nashville
RECRUITING
Deep Blue Retina, Southaven
RECRUITING
University Retina and Macula Associates, Oak Forest
RECRUITING
Retina Foundation of the Southwest, Dallas
COMPLETED
Valley Retina Institute, McAllen
WITHDRAWN
Retinal Consultants of Arizona LTD, Retinal Research Institute, Phoenix
RECRUITING
Jules Stein Eye Institute, Los Angeles
RECRUITING
Kaiser Permanente Riverside Medical Center, Riverside
RECRUITING
Stanford University Byers Eye Institute, Palo Alto
WITHDRAWN
University of Washington, Seattle
RECRUITING
Spokane Eye Clinical Research, Spokane
WITHDRAWN
Mass Eye and Ear Infirmary Ophthalmology Clinical Research Office, Boston
RECRUITING
Ophthalmic Consultants of Boston, Boston
WITHDRAWN
NJ Retina, New Brunswick
Astellas Institute for Regenerative Medicine
INDUSTRY